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Background: In pigs, diseases of the respiratory tract like pleuropneumonia due to Actinobacillus pleuropneumoniae
(App) infection have led to high economic losses for decades. Further research on disease pathogenesis, pathogen-
host-interactions and new prophylactic and therapeutic approaches are needed. In most studies, a large number of
experimental animals are required to assess lung alterations at different stages of the disease. In order to reduce the
required number of animals but nevertheless gather information on the nature and extent of lung alterations in
living pigs, a computed tomographic scoring system for quantifying gross pathological findings was developed. In
this study, five healthy pigs served as control animals while 24 pigs were infected with App, the causative agent of
pleuropneumonia in pigs, in an established model for respiratory tract disease.
Results: Computed tomographic (CT) findings during the course of App challenge were verified by radiological
imaging, clinical, serological, gross pathology and histological examinations. Findings from clinical examinations and
both CT and radiological imaging, were recorded on day 7 and day 21 after challenge. Clinical signs after
experimental App challenge were indicative of acute to chronic disease. Lung CT findings of infected pigs
comprised ground-glass opacities and consolidation. On day 7 and 21 the clinical scores significantly correlated with
the scores of both imaging techniques. At day 21, significant correlations were found between clinical scores, CT
scores and lung lesion scores. In 19 out of 22 challenged pigs the determined disease grades (not affected, slightly
affected, moderately affected, severely affected) from CT and gross pathological examination were in accordance.
Disease classification by radiography and gross pathology agreed in 11 out of 24 pigs.
Conclusions: High-resolution, high-contrast CT examination with no overlapping of organs is superior to
radiography in the assessment of pneumonic lung lesions after App challenge. The new CT scoring system allows
for quantification of gross pathological lung alterations in living pigs. However, computed tomographic findings are
not informative of the etiology of respiratory disease.* Correspondence: carsten.brauer@tiho-hannover.de
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For decades, respiratory tract diseases in pigs have led to
high economic losses in pig producing countries. Acute
disease outbreaks can often be immediately diagnosed
based on the detection of clinical signs by farmers and
veterinarians, while chronic and subclinical respiratory
disorders are difficult to diagnose. In cases with chronic
disease, gross pathology at abattoir slaughter provides
the only indication of disease presence. In contrast to
many diagnostic methods available for detecting bacterial
and viral respiratory pathogens in samples of living pigs,
methods to diagnose the extent of lung lesions in chron-
ically diseased animals, usually showing no clinical signs,
are very limited [1].
Actinobacillus pleuropneumoniae (App), the causative
agent of pleuropneumonia in pigs is one of the most im-
portant bacterial lung pathogens in swine and is com-
monly used as a standard model for respiratory disease
[2-5] and was therefore chosen for this study. App is
considered both, as a primary and secondary pathogen.
In combination with other viral and bacterial pathogens
it belongs to the “Porcine Respiratory Disease Com-
plex“(PRDC), representing a typical health problem in
pigs [2,6]. Co-infection with Mycoplasma hyopneumo-
niae can lead to respiratory diseases with high morbidity
and mortality [3,7-11].
During the peracute form of disease due to App, sud-
den death is often the sole finding without premonitory
signs, while acute disease is characterised by fever, leth-
argy, cyanosis, frothy nasal discharge, dyspnea and
coughing. Acute signs dissipate during the chronic stage
of the disease which is associated with intermittent
coughing, reduced growth and feed conversion efficiency
[2,5]. Often, subclinically and chronically infected ani-
mals do not show any clinical symptoms. As App is com-
monly endemic in pig populations, antibody detection by
serological tests does not enable discrimination between
subclinical infection and disease [12-15].
Typical lung alterations during the acute phase of an
App infection are necrotising and fibrohaemorrhagic
pneumonia associated with pleurisy [16-18]. Fibrous adhe-
sions between the parietal and visceral pleura and consoli-
dations in the form of abscess-like nodular lesions
encapsulated by connective tissue are a characteristic gross
pathological finding in the chronic stage of the disease [5].
A tentative diagnosis of App presence can be made on the
basis of the clinical signs [5], and gross pathology is con-
sidered characteristic but not pathognomonic [17]. Thus,
only organism detection from affected lung tissue by bac-
teriology or PCR provides a definitive diagnosis [5,19,20].
New prophylactical and therapeutic approaches for re-
spiratory diseases in pigs are crucial. Standardised animal
challenge models including sequential examinations after
experimental challenge are the current method of choicefor clinical studies to evaluate such new approaches.
However, these animal experiments require a large num-
ber of test animals, because necropsy has to be carried
out successively at different time points.
The aim of the present study was to detect gross
pathological lung lesions in living animals by computed
tomography (CT). The diagnostic potential and limita-
tion of this imaging method was analysed in comparison
to digital radiography. Sequential euthanasia and nec-
ropsy of test animals during the course of this study were
replaced by CT examinations. A CT scoring system for
disease classification was developed, allowing for quanti-
fication of pneumonic lung alterations. CT findings dur-
ing the course of the App infection were compared to
findings from clinical, serological and radiological exami-
nations. At the end of the study on day 21, CT findings
were also compared to findings from gross pathology
and histological examinations. Ultimately, the CT meth-
odology is expected to reduce the number of test animals




After challenge, the animals showed variable disease sever-
ity. On day 7 the clinical score ranged from 0.40 to 26.90
and on day 21 from 0.60 to 2.98 (Table 1). There were five
animals on day 7 and three animals on day 21 free of clin-
ical signs. Mild symptoms were observed in three animals
on day 7 and in 17 animals on day 21. Two animals
showed typical symptoms of App infection with a rise in
body temperature up to 41.8°C, apathy, dyspnoea and
anorexia on both examination days. Two animals (Nos 10,
9) were euthanized on days 1 and 3 post-challenge, re-
spectively, due to generalised severe disease signs, includ-
ing severe dyspnea. Nevertheless, they underwent CT and
radiographic examination prior to gross pathological
examination. Findings from those two animals were
included in the day 7 analyses. No signs of respiratory dis-
ease were detected in the control group.
Radiographic examination
Radiologic images from diseased animals revealed diffuse
shadings, increased tissue density around bronchi and
shading overlapping the cardiac and diaphragmatic sil-
houettes (Table 2, Figure 1a, 1b and 1c).
In the challenge group, radiographic scores ranged from
1 to 36 on both examination days (Table 1). Based on
radiographic scores, 6 out of 29 pigs in the challenge group
at day 7 and 5 out of 27 pigs at day 21 were classified as
not diseased (radiographic score≤ 4), while all 5 control
pigs at days 7 and 21 were classified as not diseased
(Table 1). Table 3a, 3b and 3d compare the allocation of
animals to disease class by radiographic score at days 7 and
Table 1 List of individual respiratory disease scores in the control and challenge group
CT score radiographic
score




pig day 7 day 21 day 7 day 21 day 7 day 21 day 21 day 21
control
group
1 0.00 0.00 0.00 0.00 0.30 0.50 0.00 −
2 0.00 0.21 2.00 1.00 0.72 0.10 7.04 −
3 0.00 0.00 0.00 0.00 0.50 0.20 3.57 −
4 0.00 0.00 1.00 1.00 0.60 0.70 0.00 −
5 1.30 0.29 3.00 3.00 0.53 0.30 3.57 −
median 0.00 0.00 1.00 1.00 0.53 0.30 3.57
mean 0.26 0.10 1.20 1.00 0.53 0.36 2.84
SD 0.58 0.14 1.30 1.22 0.15 0.24 2.95
challenge
group
6 0.00 0.00 1.00 2.00 0.40 1.30 0.00 −
7 0.00 0.00 3.00 2.00 0.90 1.00 0.00 −
8 1.10 1.10 16.00 16.00 3.07 0.81 6.32 +
91 5.20 36.00 19.10 31.431 +1
102 6.92 32.00 26.90 20.002 +2
11 2.70 1.60 12.00 14.00 2.60 2.06 4.39 +
12 2.97 2.21 15.00 12.00 2.80 1.03 6.35 +
13 3.21 2.23 21.00 25.00 2.80 0.89 12.33 +
14 0.00 0.00 2.00 2.00 0.60 0.60 0.00 −
15 0.00 0.23 4.00 1.00 1.33 0.70 0.00 −
16 1.34 1.07 12.00 11.00 2.26 0.73 5.40 +
17 1.35 0.24 5.00 10.00 1.12 0.93 1.84 +
18 2.05 3.71 26.00 23.00 1.96 2.98 21.65 +
19 2.38 1.21 24.00 22.00 1.36 2.81 3.42 +
20 2.45 1.39 13.00 10.00 1.89 0.70 3.00 +
21 2.80 1.98 14.00 4.00 1.63 1.03 5.13 +
22 0.00 0.00 10.00 12.00 0.60 1.90 0.00 −
23 0.88 1.48 4.00 7.00 1.70 2.27 2.63 +
24 1.23 0.00 4.00 8.00 0.50 1.80 0.00 +
25 1.34 0.61 9.00 8.00 0.90 2.10 1.60 +
26 2.15 1.79 26.00 15.00 2.57 1.87 8.46 +
27 3.34 1.39 7.00 7.00 2.07 1.90 5.20 +
28 0.30 0.00 10.00 15.00 0.70 1.60 0.00 +
29 0.00 0.00 10.00 9.00 0.90 1.70 0.00 −
mean 1.82 1.01 13.17 10.68 3.36 1.49 5.80
SD 1.75 1.00 9.73 6.81 6.21 0.70 8.05
*Quantification of clinical signs by scoring system of Höltig et al. (2008). Day 7: not affected 0–0.7, slightly affected 0.71–7.13, moderately affected 7.14–13.56,
severely affected >13.56. Day 21: not affected 0–2, slightly affected 2.01–34.70, moderately affected 34.71–67.3, severely affected >67.3.
1day 3 post challenge (euthanized on day 3 post challenge), 2day 1 post challenge (euthanized on day 1 post challenge), SD standard deviation.
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CT investigation
CT scores developed in this study ranged from 0 to 6.92
on day 7 and from 0 to 3.71 on day 21 in the challengegroup (Table 1). Following the CT examination on day 7,
six animals in the challenge group showed no patho-
logical changes, while the other challenged animals
showed ground-glass opacities or consolidations of vary-
ing degrees. At day 7, one of the 5 control pigs was clas-
sified as slightly affected (CT score 1.30).
Table 2 Evaluation of digital radiographic findings
Finding Points
Heart shadow/visible diaphragmatic shadow 0
No increased tissue density around bronchi 0
No shading of the lung tissue 0
Heart shadow/diaphragmatic shadow visible,
but superimposed by diffuse opacities
1
Mild increase in tissue density around bronchi 1
Mild diffuse shading of the lung tissue 1
Heart shadow/diaphragmatic shadow not visible 2
Severe increase in tissue density around bronchi 2
Severe diffuse shading of the lung tissue 2
Well-defined areas of high density 3
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were observed in 14 animals in the challenge group and
also in 2 pigs in the control group (Table 1, Figure 2a, 2b).
On days 7 and 21, 19% and 13% of the pathological
changes were in the area of the apical lobes, respectively,
38% and 42% in the area of the cardiac lobe and 43% and
45% in the area of the diaphragmatic lobes, respectively.
In general, ground-glass opacities were recorded by
transverse sections as hazy, diffuse and non-homoge-
neous areas of increased lung tissue density due to
decreased aeration and characterised by distinct outlines
of the bronchial tree and vasculature. In contrast, conso-
lidations were focal, homogeneous areas, with defined
margins and an increase in lung density. The underlying
blood vessels and airway walls were obscured.The aver-
age density values (HU) of the consolidations were in the
positive range of the Hounsfield Scale on both examin-
ation days after challenge.Gross pathology and bacteriology
Lung lesion scores ranged from 0 to 31.43. The highest
lung lesion score in an animal surviving until day 21 was
21.65. At necropsy, eight challenged animals and two
animals from the control group lacked any gross patho-
logical changes (Table 1). Six animals from the challengeFigure 1 Digital radiography of the thorax on day 21 post challenge.
side. Arrows show focal lesions.group and 2 animals from the control group were classi-
fied as slightly affected (Table 3 c, d). One animal in the
control group classified as moderately affected had lung
tissue consolidation within the right apical lobe that was
considered atypical of App infection, on the basis of
histological and bacteriological findings (cartarrhal and
purulent bronchopneumonia with isolation of Bordetella
bronchiseptica and Mycoplasma flocculare) and negative
for App. A slight interstitial pneumonia was examined in
all control animals by histological examination.
29% of gross lung lesions were located in the apical,
24% in the cardiac and 47% in the diaphragmatic lobes.
The cut surfaces of the multiple, dark red and demar-
cated consolidated foci were coloured grey-red to off-
white (Figure 3a and 3b). In addition, in 16 pigs from the
challenge group, fibrinous pleurisy and adhesions were
detected. Many pigs showed abscess-like nodules encap-
sulated in connective tissue. One of the two pigs eutha-
nized before day 7 showed excessive serosanguinous
fluid in the thoracic cavity. In both pigs euthanized be-
fore day 7, approximately 50% of lung tissue was
affected. In the remaining animals the proportion of
grossly affected lung tissue ranged from 3.5% to 50% of
the total lung tissue.
The recovery of App from lung tissue by bacterio-
logical examination and confirmatory PCR was success-
ful in both animals euthanized prior to day 7 after
challenge and in 16 of the remaining 22 challenged ani-
mals (73%) at day 21. The 6 bacteriologically negative
pigs in the challenge group all had no gross lesions of
App and all were classified as unaffected by CT score
(Tables 1, 3).
Bacteriological examination of lung tissue of control
animals resulted in the detection of Bordetella bronchi-
septica, E. coli and alpha-haemolytic streptococci, while
App was not isolated.Correlation of scores
On days 7 and 21, clinical scores significantly correlated
with scores of both imaging techniques. On both days,
radiographic scores positively correlated with computed(a) dorso-ventral view, (b) lateral view, left side, (c) lateral view, right
Table 3 Classification of disease severity using radiographic, lung lesion and CT scores
a) Classification of pigs based on disease severity assessed by CT score and radiographic score on day 7 post challenge












0 5 (17. 2%) 2 (6.9%) 2 (6.9%) 9 (31.0%)
moderately affected
(1.71–2.22)
0 0 2 (6.9%) 0 2 (6.9%)
slightly affected
(0.24–1.70)
3 (10.3%) 4 (13.8%) 1 (3.5%) 0 8 (27.6%)
not affected
(0–0.23)
8 (27.6%) 2 (6. 9%) 0 0 10 (34.5%)
Total 11 (37.9%) 11 (37.9%) 5 (17.3%) 2 (6.9%) 29 (100.00%)
b) Classification of pigs based on disease severity assessed by CT score and radiographic score on day 21 post challenge












0 0 2 (7.4%) 0 2 (7.4%)
moderately affected
(1.71–2.22)
1 (3.7%) 2 (7.4%) 0 0 3 (11.1%)
slightly affected
(0.24–1.70)
1 (3.7%) 7 (26.0%) 2 (7.4%) 0 10 (37.1%)
not affected
(0–0.23)
8 (29.6%) 4 (14.8%) 0 0 12 (44.4%)
Total 10 (37.0%) 13 (48.2%) 4 (14.8%) 0 27 (100.00%)
c) Classification of pigs based on disease severity assessed by CT score and lung lesion score












0 0 0 4 (13.8%) 4 (13.8%)
moderately affected
(1.71–2.22)
0 0 3 (10.4%) 0 3 (10.4%)
slightly affected
(0.24–1.70)
0 7b (24.1%) 3 (10.3%) 0 10 (34.4%)
not affected
(0–0.23)
10a (34.5%) 1b (3.5%) 1b (3.4%) 0 12 (41.4%)
Total 10 (34.5%) 8 (27.6%) 7 (24.1%) 4 (13.8%) 29 (100.0%)
d) Classification of pigs based on disease severity assessed by radiographic score and lung lesion score
radiographic score* on
day 21 post challenge










severely affected>26 0 0 0 2 (6.9%) 2 (6.9%)
moderately affected16–26 0 1 (3.5%) 1 (3.5%) 2 (6.9%) 4 (13.8%)
slightly affected5–15 4 (13.8%) 5b (17.2%) 4 (13.8%) 0 13 (44.8%)
not affected0–4 6a (20.7%) 2b (6.9%) 2b (6.9%) 0 10 (34.5%)
Total 10 (34.5%) 8 (27.6%) 7 (24.1%) 4 (13.8%) 29 (100.00%)
*[21],**[22].
aincluding two control pigs, bincluding one control pig.
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P = 0.0014, respectively). On day 21, the lung lesionscores were found to positively correlate with clinical
scores, radiographic scores and with computed
Figure 2 CT-sectional image. (a) of the thorax of a pig at the level of the 7th thoracic vertebra on day 21 post-challenge, sternal recumbent
position, lung window (W:1500HU/L:-600HU), (1) liver, (2) hyperdense, focal consolidation in the right diaphragmatic lung lobe; (b) of the thorax
of a pig at the level of the 8th thoracic vertebra on day 21 post-challenge, sternal recumbent position, lung window (W:1500HU/L:-600HU), (1)
liver. Arrows show ground-glass opacities.
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efficient of the lung lesion scores with the CT scores
(r = 0.8206, P< 0.0001) was higher compared to the
radiographic scores (r = 0.4733, P = 0.0126). In order to
translate the CT scores to four respiratory disease classes
(not affected, slightly affected, moderately affected, se-
verely affected), boundary values of the four CT score
classes were chosen to achieve maximum concordance
with the lung lesion score disease classes (Table 3c). An
agreement in the assessment of disease severity with
both methods was maximized by testing potential cut
points for disease classes defined by the CT score in a
contingency table. Disease classification by the different
scoring schemes is summarized in Table 3.
On day 7, 55.2% of the animals were assigned to identical
disease classes by both imaging methods, while 10.4% of
the pigs were judged to be more affected based on x-ray
and 34.4% were judged more severely ill by CT. On day 21,
55.6% of the animals were assigned to identical disease
classes by CT and radiography, while 22.2% of the pigs
were judged more severely ill by CT and 22.2% by x-ray
compared to CT examination. Compared to grossFigures 3 Lung changes caused by App (a and b) on day 21 post challepathology, results of radiographic examination at day 21
were accordance in 48.3% of pigs, while 17.2% were judged
to be more affected according to radiography, i.e., 34.5%
were judged as less affected by radiography. After
maximization of the agreement between disease classes
defined by the CT score and the established lung lesion
score 82.8% of the pigs were assigned to identical disease
classes by gross pathology and CT examination on day 21.
17.2% were classified as more severely affected by gross
pathology than by CT examination, and no animals were
assessed as more severely affected by CT. For the detection
of lung changes, the positive predictive value of CT was
calculated to be 100% and the negative predictive value
was 83% (confidence limits 62–100%, 95% level of
confidence).
Discussion
The impact of computed tomography in veterinary medi-
cine has increased during the last few years. Especially in
small animals and horses CT is useful because of its rou-
tine feasibility and diagnostic reliability [23,24]. In con-
trast, CT has not been established as a routine imagingnge. Arrows show abscess-like nodules encapsulated in connective tissue.
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gation costs, time-consuming and personnel-intensive
procedures and limited availability of equipment. In
addition, CT examination of large animals is limited by
the gantry diameter of most CT devices (600 mm) as
well as size and capacity of the examination table with a
maximum load of 160 kg [25]. Therefore, as described by
Barbee and Allen (1990), CT examinations in horses are
only carried out on the head, neck and limbs [25]. Com-
puted tomography in pigs as animal models for human
medicine has been used in several studies [26-28].
The aim of this study was to investigate the characteris-
tic morphological alterations of lung tissue after experi-
mental App challenge using computed tomography in
pigs. Furthermore, the diagnostic potential and limitations
of CT in pigs were compared with those of digital radiog-
raphy. On the basis of the collected CT findings in living
animals, a quantitative scoring system for determining the
lung status of diseased pigs was derived. This scoring sys-
tem is of high practical importance for follow-up studies
during the course of experimental challenges with App but
can not be transferred to other respiratory pathogens. The
CT protocol used, based on 7 mm slices and a reconstruc-
tion interval of 5 mm was found appropriate for the detec-
tion of macroscopic lung lesions attributed to App. The
detection of microscopic lung changes such as interstitial
pneumonia (which may be a finding in viral pneumonias)
is expected to require slices as narrow as 1 mm [29,30].
These conditions could not be achieved with the type of
CT equipment and the short examination times used in
our study. The examination time limit has not been deter-
mined in this study. It depends on the length of time the
pigs remain anaesthetised and the speed of data capture by
the CT equipment.
The clinical signs after experimental App challenge of
24 pigs ranged from nil to severe symptoms, with two
affected animals requiring euthanasia due to severe dys-
pnoea on days 1 and 3, respectively. These results were
reflected in the gross pathological findings which ranged
from normal lungs to severe pleuropneumonia.
CT examination of animals in the challenged group
showed ground-glass opacities and consolidations on
days 7 and 21. Ground-glass opacities are caused by par-
tial filling of the alveolar spaces, by thickening of the
interstitium, partial collapse of alveoli, or an increased
capillary blood volume [31,32]. As shown in several other
studies, App infections are accompanied by swelling of
capillary endothelia and thickening of alveolar septa in
the first hours after challenge, followed by fibrinous ex-
udation, migration of inflammatory cells and haemor-
rhage [16,17]. These pathological changes were found by
CT examination in the form of hazy areas with an in-
crease in lung density as well as more prominent bron-
chial and vascular outlines.Consolidations are caused by an accumulation of transu-
date or exudate, which replace the alveolar air or by a col-
lapse (atelectasis) in lobules. Therefore, they can be
distinguished from ground-glass opacities because of the
obscured underlying vessels and airway walls [32]. In the
present study CT-diagnosed consolidations appeared as
focal, homogeneous compaction of the lung with obliter-
ation of the vascular and bronchial walls. These changes
are due to focal necrosis, edematous and widened intersti-
tia and serofibrinous exudates. According to the cross-sec-
tional CT images, typical lesions caused by App were
characteristically distributed throughout the lungs with a
higher prevalence in the diaphragmatic lobes [5,8,10]. A
quantitative measurement of lung tissue density for char-
acterising macroscopic and microscopic lung tissues
alterations using CT is possible, however, with some lim-
itations [33,34]. The measurement of tissue density was
used to characterise consolidations typical for App infec-
tion such as abscess-like nodules encapsulated in connect-
ive tissue. Galanski (1998) described the density value of
abscesses ranging between 0 and 80 HU while pure pus
has a CT value of 30 HU [33]. Others have found connect-
ive tissue formation and necrotic processes after experi-
mental piglet infection with Bordetella bronchiseptica and
Pasteurella multocida were of high densities (0 to 150
HU) in CT scans [35]. The average density of consolida-
tions occurring in this study was also in the positive range
of the Hounsfield scale compared to the physiological
density of lung tissue which ranges from −550 HU to −950
HU [36]. Therefore, density measurement enabled a tenta-
tive diagnosis of the presence of accumulated pus, abscess-
like nodules and necrotic areas.
Density measurements in areas with non-homoge-
neous, partially compacted and poorly defined ground-
glass opacities cannot be performed [37]. Within these
areas varying densities at the observation time occurred
due to spontaneous breathing with varying inspiration
depth. This variability resulted in high standard devia-
tions of the measured values. Others have indicated that
reproducible density measurements over time are only
feasible at controlled inspiration depth [36].
Both the CT and the x-ray examinations strongly cor-
related with each other and with the clinical findings on
days 7 and 21. However, for assessing the extent of lung
alterations, a clinical scoring scheme alone is considered
insufficient [38], due to the fact that severe tissue dam-
age can be compensated by remaining parenchyma with-
out clinical manifestation [1,21]. This observation is
supported by our finding that clinical scores showed only
a weak correlation with gross pathological findings at the
end of the experiment.
Frequencies of cases within the severity classifications
by CT, x-ray and necropsy were not consistent in all
instances. As shown in this and other studies, pleurisy
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tiated from other gross pathological changes by CT and
radiographic examination [21,39]. In some cases, false
positive radiographic findings may occur especially in
spontaneously breathing animals if the recordings are
not carried out at the point of maximum inspiration [40-
42]. False negative results may be due to the curvature of
the diaphragm, hiding lung changes, including enlarged
lymph nodes within the caudal lobes [43]. On the other
hand, CT examination without overlapping organs, com-
bined with cross-sectional images and a precise knowledge
of anatomical structures enables the recognition of small
lung tissue abnormalities. CT score graduation and its as-
signment to disease severity were chosen to ensure the
best concordance with the disease classes defined by the
lung lesion score. Therefore, the disease severity score
graduation developed in the present study should be con-
sidered a preliminary guide for the quantification of App
induced lung lesions and should be further validated in a
larger cohort study. CT of the thorax could also be evalu-
ated in caesarian-derived, colostrum-deprived or in gnoto-
biotic piglets, because these are widely used for challenge
experiments in human medicine.
Our current approach compared the CT methodology
with other methods that have been established in con-
ventional pigs. Based on our findings, it is possible to de-
tect gross pathological lung tissue changes in living pigs,
which can be applied to efficacy studies of drugs and
vaccines, or pathogenesis studies at certain points of
time. In the context of ethical considerations, the num-
ber of animals can be reduced, since animals do not have
to be sacrificed and necropsied at different time points
to monitor the course of infection.
Conclusion
CT thorax examination facilitated a high-contrast repre-
sentation of characteristic but not pathognomonic App
induced lung alterations. Although CT examination is
superior to radiography and can therefore be recom-
mended for scientific application, radiography can also
be used for diagnosing gross pathological lung changes
in subclinically-affected pigs. However, the additional as-
sessment of disease history, histological examination and
microbiological findings is still indispensable for accurate
diagnosis of respiratory diseases in pigs.
Methods
Experimental setup
This study was conducted over a period of 21 days. After
an acclimation period lasting several days, all animals
were subjected to a daily general clinical examination.
The animals were carefully monitored for signs of re-
spiratory disease. After familiarisation, pigs in the chal-
lenge group were exposed to App, using an aerosolchamber. Control animals underwent mock challenge
under the same conditions. On days 7 and 21, a digital
radiographic and CT examination was performed. On
day 21, all animals were euthanized, followed by nec-
ropsy and gross pathological examination of lung tissue.
Animals
29 clinically healthy German Landrace pigs (male, neu-
tered) aged 7 weeks, with an average body weight of
13.7 kg were used. Because it was known from previous
experiments that approximately one third of the animals
will not develop gross lung lesions, a total of 24 pigs
were challenged. Pigs originated from a closed breeding
herd of high health status that routinely tested seronega-
tive for App and selected other pathogens on multiple
occasions at six-monthly intervals. All pigs used in this
study were tested negative for App antibodies prior to
the study and were randomly allocated to a treatment
group of 24 animals and a control group of 5 animals.
The pigs were housed and cared for under the same con-
ditions and in accordance with the Directive of the Euro-
pean Convention for the Protection of Vertebrate
Animals Used for Experimental and Other Scientific Pur-
poses (European Treaty Series, nos. 123 [http://conven-
tions.coe.int/treaty/EN/treaties/html/123.htm] and 170
[http://conventions.coe.int/treaty/EN/treaties/html/170.
htm]). Pigs of the control group were housed in an isola-
tion unit separated from the group of challenged pigs.
Air supply in each unit was assured by separated ventila-
tion ducts. Challenged pigs and control pigs were looked
after by different personnel to avoid cross-infection due
to indirect contact between both groups. The study was
approved from the local regulatory authorities and in ac-
cordance with the requirements of the national animal
welfare law (approval number: 33.9-42502-04-05/919).
Aerosol challenge
For aerosol challenge an App serovar 7 strain (AP76)
was used, as this strain exhibits moderate virulence due
to a lack of the cytotoxic and haemolytic Apx toxins I
and III. Challenge experiments with strain AP76 have
been performed on several occasions by our group and
the dose chosen was previously shown to result in low
mortality and chronic lung pathology [44,45].
App was cultured at 37°C and 5% CO2 in PPLO
medium or on PPLO agar (Difco GmbH, Augsburg, Ger-
many), supplemented with NAD (10 μg/ml; Merck,
Darmstadt, Germany), L-cysteine hydrochloride (260 μg/
ml; Sigma, Deisenhofen, Germany), L-cystine dihy-
drochloride (10 μg/ml; Sigma), dextrose (1 mg/ml; Roth,
Karlsruhe, Germany), and Tween (0.1%). For preparation
of challenge dose PPLO medium was inoculated with
single colonies from PPLO agar and incubated overnight
without shaking. Fresh PPLO medium was then
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bated with shaking at 180 rpm to reach an OD of ap-
proximately 0.45 at 600 nm. This culture was
subsequently diluted 1:15,000 with 0.9% sterile NaCl so-
lution (154 mM). Animals were brought into an aerosol
chamber in groups of four and 13 ml of the diluted cul-
ture (approximately 2 × 105 colony forming units of App)
was aerolized in the chamber within two minutes at a
pressure of 2 bar [21,46-48]. Upon aerosolization a dose
of approximately 1 × 102 App cells per litre of aerosol
had been titrated in preliminary trials. Pigs were exposed
for 10 mins to the aerosol in the closed chamber. An ali-
quot of the diluted culture was serially diluted and plated
onto PPLO agar plates for overnight culture and retro-
spective confirmation of the challenge dose.
Animals in the control group underwent mock chal-
lenge under the same conditions using 0.9% sterile NaCl
solution (154 mM).
Clinical examination
Clinical examination was based on a clinical scoring sys-
tem as previously described but without pulse oximetry
monitoring [21]. Changes in general health as a result of
a respiratory disease and clinically detectable deviations
from the physiological breathing process were assessed.
The scoring system included the following ten para-
meters: breathing noise, type of respiration, respiratory
rate, coughing, colouration of the skin surface, posture,
behaviour, feed intake, body temperature and vomiting.
Cumulative clinical scores for each pig on day 7 and day
21 after challenge were calculated as the sum of scores
for all daily examinations performed until that day (sum
of daily clinical scores from day 1 to 7 and from day 1 to
21, respectively). Disease classifications by clinical scores
on day 7 after challenge were: not affected (0–0.70),
slightly affected (0.71–7.13), moderately affected (7.14–
13.56), severely affected (>13.56). Disease classifications
by clinical scores on day 21 after challenge were: not
affected (0–2.00), slightly affected (2.01–34.70), moder-
ately affected (34.71–67.3), severely affected (>67.3).
Radiographic examination
For digital radiographic and computed tomographic
examinations the animals were anaesthetised with Keta-
mine (15–20 mg/kg body weight intramusculary (i.m.),
Ursotamin, Serum-Werk Bernburg-AG, Bernburg, Ger-
many) and Azaperone (2 mg/kg body weight i.m., Stres-
nil, Janssen-Cilag GmbH, Baar, Switzerland). The
radiographic and CT results were judged by one
investigator.
Digital x-ray examination
Digital x-ray examination of the thorax was performed
with a 80 kV no-scatter grid and automatic exposure(Precimat, manufactured by Picker International., Mun-
ich, Germany). To assess the left and right lung, record-
ings were made using a lateral path of x-rays on both
sides. For this purpose the animals were placed in lateral
recumbency. A dorso-ventral recording was then per-
formed in sternal recumbency with the legs extended
[49]. The film-focus distance was 1.5 m. Image plate cas-
settes (EURAS MedTech, PROVOTEC, X-RAY, Espelk-
amp, Hannover, Germany) sized 240 × 300 mm were
used and readout linearly with the iCR 3600, a digital
non-contact image storage system (EURAS MedTech,
PROVOTEC, X-RAY, Espelkamp, Hannover, Germany).
A class A black and white monitor (firm, flat Medic)
with the software digipaX (digipaX GmbH, Leipzig, Ger-
many) was used to view the images, which were inter-
preted objectively following a previously published
radiographic score system [21] based on dividing the
right and left lung into quadrants (eight sections). Each
quadrant was evaluated by examination of the dorso-
ventral and lateral views. Scores for various radiographic
findings (Table 2) were added to determine the score of
the respective quadrant. Finally, the added scores of the
eight quadrants provided the radiographic score for the
whole lung.
CT examination
A third generation single-slice spiral CT (Tomoscan M,
Philips Company, Hamburg, Germany) was used for the
investigations. The scanogram and volume scan was per-
formed with the following settings: tube voltage 120 kV,
current 40 mA, slice thickness 7 mm, reconstruction
interval 5 mm, pitch 1.5. The matrix was 512 × 512 pix-
els. The animals were placed symmetrically in sternal re-
cumbency and scanned from the cranial thoracic
aperture to the caudal end of the lung. Imaging was per-
formed without a contrast agent. A standard Windows
PC and an image reporting and processing software for
medical diagnostics (e-film, eFilm Medical Inc., Toronto,
Ontario, Canada) were used to save and evaluate the ab-
sorption and density measurements of the CT scans. The
CT images were displayed with conventional window
settings specific for lung tissue (window width, 1500
Hounsfield units (HU); and window level - 600 HU). CT
images were assessed visually by one blinded investigator
and pathological changes were evaluated for morphology
(ground glass opacity, consolidation), distribution pat-
tern, localisation and absorption density.
In order to describe the localisation of lesions, the lung
area was divided into three sections, i.e. cranial, middle,
caudal. Because lung lobes are not vertically defined they
overlap multiple vertebrae so that the compartmentation
serves only for rough orientation: The cranial section
was located between the first and the fourth thoracic
vertebrae and contained mainly the apical lobes. The
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sixth thoracic vertebrae and contained mainly the car-
diac lobes. Finally, the caudal section was located be-
tween the sixth and the eleventh vertebrae and
contained predominantly the diaphragmatic lobes and
the accessory lobe. For each transverse cross-section of
the lung, four quadrants (left-dorsal, left-ventral, right-
dorsal, right-ventral), were examined for pneumonic
changes [50]. Consolidations and ground glass opacities
were scored, with one scoring point being assigned for
each involved quadrant. Pathological changes in all four
quadrants resulted in a maximum score of four points.
The CT scoring system also included density assessment
of the consolidations detected. Absorption density meas-
urement was based on selecting the centre of a consolida-
tion in any transverse section as a circular region of
interest (ROI) with an area of 120 mm2 as previously
described [51]. The mean density value (HU; mean
Hounsfield Unit) and standard deviation were calculated
from the absorption density of the pixels in the selected
area. When scoring each transverse cross section, the con-
solidation with the highest density was taken into account
as follows: < − 550 HU no scoring points; from - 550 to -
150 HU two scoring points; and>− 150 HU four scoring
points. Thus the scores for the number of pathologically
altered quadrants per image (maximum of four) and the
scores for consolidations based on the highest density
(maximum of four) were added and divided by the total
number of transverse sectional images, so that a maximum
of eight points per pig could be achieved.
Spearman’s rank correlation coefficients between the
individual scores (clinical, radiographical, CT, lung le-
sion) were calculated for days 7 and 21. Pigs were allo-
cated to ranges of CT scans based on findings of gross
pathology (lung lesion scores), which indicated CT cut-
points of 0.24, 1.71 and 2.23 gave the best correlation
with slight, moderate and severe disease respectively.
Pathological and bacteriological examination
At necropsy, lungs were examined by gross pathology.
Findings were quantified using the Lung Lesion Score
(LLS) proposed by Hannan et al. (1982) and specified in
the European Pharmacopoeia for vaccine development
[22,52]. For this purpose, a schematic map of the porcine
lung was used. In this map the lung was subdivided into
74 triangles, with 7 in each of the apical and cardiac
lobes, 8 in the accessory lobe and 19 in each diaphrag-
matic lobe. Each lobe may contribute a maximum score
of 5. To determine the LLS, the damaged area was deter-
mined by counting the number of triangles with patho-
logical changes and expressing it as a fraction of five for
each lobe. The values for each lung lobe were summed,
resulting in an LLS with a maximum possible score of
35.Reisolation of App was achieved by plating tissue of
each of the seven lung lobes on selective meat and blood
agar [53]. Bacteriological confirmation of App was subse-
quently performed by PCR for the ApxIIA gene and by
testing for urease activity [44,47,54]. Lung tissue of chal-
lenged animals was not examined for other bacterial spe-
cies, while lung tissue of animals from the control group
was examined for App and other bacterial species.Acknowledgments
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